Skip to main content
BECTON DICKINSON & CO logo

BECTON DICKINSON & CO — Investor Relations & Filings

Ticker · BDX ISIN · US0758871091 LEI · ICE2EP6D98PQUILVRZ91 US Manufacturing
Open in API
Filings indexed 3,016 across all filing types
Latest filing 2026-05-29 Regulatory Filings
Country US United States of America
Listing US BDX

About BECTON DICKINSON & CO

https://www.bd.com/

Becton, Dickinson and Company (BD) is a global medical technology company dedicated to advancing the world of health by improving medical discovery, diagnostics, and the delivery of care. The company manufactures and sells a comprehensive portfolio of medical supplies, devices, laboratory equipment, and diagnostic products. Its offerings support healthcare providers, life sciences researchers, clinical laboratories, and the pharmaceutical industry. Key areas of focus include medication management systems, infection prevention, drug delivery devices, and advanced diagnostic and research tools designed to enhance patient safety, improve clinical outcomes, and increase operational efficiencies.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings Classification · 90% confidence The document is an SEC Form 8-K “Current Report” filed under Section 13 or 15(d) of the Exchange Act, disclosing a Regulation FD event regarding product shipment resumption after an FDA Warning Letter. It is a regulatory compliance filing rather than an earnings report, management discussion, or financial statements. This falls under the general “Regulatory Filings” category (RNS).
2026-05-29 English
SD
Regulatory Filings Classification · 85% confidence The document is a U.S. SEC Form SD (Specialized Disclosure Report) for conflict minerals, which is a regulatory filing that does not fit into any of the specific report categories such as annual or quarterly reports, proxy statements, or management presentations. It primarily provides conflict minerals information and refers to an exhibit rather than containing substantive financial data itself. Therefore, it falls under the fallback category of general regulatory filings (RNS).
2026-05-22 English
8-K
Capital/Financing Update Classification · 91% confidence The document is a Form 8-K Current Report filed under the Securities Exchange Act, detailing the entry into a material definitive agreement for a subsidiary notes offering of €600 million 3.855% notes due 2033, along with the related indenture and supplemental indenture. This constitutes a capital/financing update describing the company’s fundraising activity and change in capital structure (new debt issuance). Therefore, the correct classification is Capital/Financing Update (CAP).
2026-05-20 English
424B2 - BECTON DICKINSON & CO (0000010795) (Filer)
Capital/Financing Update Classification · 91% confidence The document is a prospectus supplement (SEC Rule 424(b)(2)) to an existing prospectus, detailing the terms of a €600,000,000 3.855% Notes due 2033 offering by Becton Dickinson Euro Finance S.à r.l., fully guaranteed by Becton, Dickinson and Company. This constitutes a capital markets fundraising document describing new debt issuance — a financing activity and capital structure change. Therefore, the appropriate category is Capital/Financing Update (CAP).
2026-05-13 English
8K
Capital/Financing Update Classification · 91% confidence The document is a Form 8-K “Current Report” filed under Item 8.01 “Other Events,” describing an underwriting agreement for the issuance of €600 million of 3.855% notes due 2033, guaranteed by the parent, and the use of proceeds to refinance existing notes. This is a financing activity update, matching the definition of a Capital/Financing Update (CAP).
2026-05-12 English
FWP
Capital/Financing Update Classification · 95% confidence The document is an SEC Rule 433 Issuer Free Writing Prospectus and pricing term sheet for a €600 million note offering by Becton Dickinson. It details the coupon, maturity, redemption terms, underwriters, and other terms of a new debt issuance. This is a direct update on the company’s financing activity—a capital raising transaction. It is not an earnings release, annual report, or management change notice. Accordingly, it falls under “Capital/Financing Update” (CAP).
2026-05-11 English

Browse filings by year

33 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.